Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials.
Higher cholesterol is strongly associated with an increased risk of coronary heart disease (CHD) in nonrenal populations, so the lack of a clear positive association between total cholesterol and mortality among dialysis patients is unexpected. This review of prospective studies of the association b...
Autors principals: | Baigent, C, Landray, M, Wheeler, D |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2007
|
Ítems similars
-
Impact of prior myocardial infarction and vascular disease on the risk of subsequent cardiac events among 68 730 patients commencing dialysis.
per: Landray, M, et al.
Publicat: (2002) -
Statin therapy in kidney disease populations: potential benefits beyond lipid lowering and the need for clinical trials.
per: Baigent, C, et al.
Publicat: (2004) -
Evidence for the prevention and treatment of stroke in dialysis patients
per: Herrington, W, et al.
Publicat: (2014) -
Benefits of lowering cholesterol in chronic kidney disease Reply
per: Baigent, C, et al.
Publicat: (2011) -
Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: Results from the study of heart and renal protection
per: Reith, C, et al.
Publicat: (2017)